Legal & General Group PLC Replimune Group, Inc. Transaction History

Legal & General Group PLC

$368 Billion
Q4 2024

A detailed history of Legal & General Group PLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 59,366 shares of REPL stock, worth $749,792. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,366

Previous 41,769 42.13%

Holding current value

$749,792

Previous $457,000 57.11%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$10.54 - $14.93 $185,472 - $262,723	17,597 Added 42.13%	59,366 $718,000
Q3 2024 Feb 28, 2025	SELL	$8.09 - $11.23 $159,656 - $221,624	-19,735 Reduced 33.24%	39,631 $434,000
Q3 2024 Nov 14, 2024	BUY	$8.09 - $11.23 $9,643 - $13,386	1,192 Added 2.94%	41,769 $457,000
Q2 2024 Aug 14, 2024	BUY	$5.01 - $9.46 $29,233 - $55,199	5,835 Added 16.8%	40,577 $365,000
Q4 2023 Feb 15, 2024	BUY	$6.75 - $16.18 $4,367 - $10,468	647 Added 1.9%	34,742 $292,000
Q3 2023 Nov 14, 2023	SELL	$15.96 - $22.18 $8,506 - $11,821	-533 Reduced 1.54%	34,095 $583,000
Q2 2023 Aug 14, 2023	BUY	$15.65 - $24.1 $222,245 - $342,244	14,201 Added 69.52%	34,628 $804,000
Q1 2023 May 15, 2023	BUY	$17.48 - $29.09 $119,965 - $199,644	6,863 Added 50.6%	20,427 $360,000
Q4 2022 Feb 14, 2023	BUY	$17.09 - $27.91 $59,456 - $97,098	3,479 Added 34.5%	13,564 $368,000
Q3 2022 Nov 14, 2022	BUY	$15.6 - $21.15 $27,471 - $37,245	1,761 Added 21.16%	10,085 $174,000
Q2 2022 Aug 22, 2022	BUY	$13.32 - $19.98 $7,006 - $10,509	526 Added 6.75%	8,324 $146,000
Q4 2021 Feb 14, 2022	BUY	$25.43 - $34.25 $788 - $1,061	31 Added 0.4%	7,798 $211,000
Q3 2021 Nov 15, 2021	BUY	$28.98 - $39.54 $127,772 - $174,331	4,409 Added 131.3%	7,767 $231,000
Q2 2021 Aug 12, 2021	SELL	$28.5 - $39.37 $1,596 - $2,204	-56 Reduced 1.64%	3,358 $129,000
Q1 2021 May 17, 2021	SELL	$30.22 - $45.57 $3,686 - $5,559	-122 Reduced 3.45%	3,414 $104,000
Q4 2020 Feb 12, 2021	BUY	$23.5 - $52.65 $24,628 - $55,177	1,048 Added 42.12%	3,536 $135,000
Q3 2020 Nov 13, 2020	SELL	$18.85 - $27.0 $6,540 - $9,369	-347 Reduced 12.24%	2,488 $57,000
Q2 2020 Aug 14, 2020	BUY	$9.76 - $25.95 $6,636 - $17,646	680 Added 31.55%	2,835 $70,000
Q1 2020 May 14, 2020	SELL	$8.9 - $19.08 $2,999 - $6,429	-337 Reduced 13.52%	2,155 $21,000
Q4 2019 Feb 13, 2020	BUY	$11.61 - $17.21 $5,201 - $7,710	448 Added 21.92%	2,492 $36,000
Q1 2019 May 15, 2019	BUY	$10.26 - $16.24 $9,326 - $14,762	909 Added 80.09%	2,044 $31,000
Q3 2018 Nov 20, 2018	BUY	$14.99 - $22.14 $17,013 - $25,128	1,135 New	1,135 $18,000

Others Institutions Holding REPL

# of Institutions

161

Shares Held

74.9M

Call Options Held

38.4K

Put Options Held

43.7K

View Full List

About Replimune Group, Inc.

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $623M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

More about REPL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Replimune Group, Inc. Transaction History